Topics:
Hematologic Malignancies • Pediatric Oncology • Medical Oncology • Bone Marrow Transplant • Hematology
How do you manage a patient with a history of high-risk leukemia who has increasing loss of donor chimerism in the post-transplant setting in the absence of disease relapse?
How does graft function play into your decision making? How do you utilize post allogeneic transplant chimerism in clinical practice? Do you obtain lineage specific chimerisms? Would you offer DLI for incomplete chimerism?
Answer from: at Academic Institution
Decline in donor chimerism is not very common in pediatric patients who underwent myeloablative conditioning regimen for hematologic malignancy, and if chimerism is initially 100% and subsequently falls, it usually represents a relapse of underlying leukemia, or a new malignancy. I always obtain lin...
Sign in or Register to read more